Fisher Buy Helps Thermo Post 240-Percent Revenue Growth in Q1; R&D Spending, Profits Also Rise | GenomeWeb
NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said first-quarter revenues increased nearly 240 percent as R&D spending rose 55 percent and profit jumped 200 on combined sales and spending stemming from the merger of Thermo Electron and Fisher Scientific.
 
Total receipts for the three months ended March 31 increased to $2.3 billion from $684.3 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.